Drug Trial Radar · NCT07734844
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
910
Planned (sponsor's estimate)
Start
Aug 3, 2026
Primary completion
Aug 31, 2028
Study completion Sep 2029
Sponsor
- Lead sponsor
- Kodiak Sciences IncIndustry
- Sponsor type
- Industry
- First posted
- Jul 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO
Conditions
- Diabetic Macular Edema (DME)
Interventions
Tabirafusp tedromerDrug
Intravitreal injection
Aflibercept (2.0 mg)Drug
Intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best corrected visual acuity (BCVA)Time frame: Week 52
Locations
52 sites in 2 countries. Site status is shown where the registry gives one.
Kodiak Research Center
Scottsdale, Arizona · Recruiting
Kodiak Research Center
Bakersfield, California · Recruiting
Kodiak Research Center
Glendale, California · Recruiting
Kodiak Research Center
Modesto, California · Recruiting
Kodiak Research Center
Oxnard, California · Recruiting
Kodiak Research Center
Pasadena, California · Recruiting
Kodiak Research Center
Redlands, California · Recruiting
Kodiak Research Center
Redlands, California · Recruiting
Kodiak Research Center
Sacramento, California · Recruiting
Kodiak Research Center
Sacramento, California · Recruiting
Kodiak Research Center
Waterford, Connecticut · Recruiting
Kodiak Research Center
Fort Lauderdale, Florida · Recruiting
Kodiak Research Center
St. Petersburg, Florida · Recruiting
Kodiak Research Center
Winter Haven, Florida · Recruiting
Kodiak Research Center
Elmhurst, Illinois · Recruiting
Kodiak Research Center
Hagerstown, Maryland · Recruiting
Kodiak Research Center
Saint Louis Park, Minnesota · Recruiting
Kodiak Research Center
Madison, Mississippi · Recruiting
Kodiak Research Center
Hauppauge, New York · Recruiting
Kodiak Research Center
Rochester, New York · Recruiting
Kodiak Research Center
Cary, North Carolina · Recruiting
Kodiak Research Center
Greensboro, North Carolina · Recruiting
Kodiak Research Center
Hickory, North Carolina · Recruiting
Kodiak Research Center
Wake Forest, North Carolina · Recruiting
Kodiak Research Center
Winston-Salem, North Carolina · Recruiting
Kodiak Research Center
Beaufort, South Carolina · Recruiting
Kodiak Research Center
Charleston, South Carolina · Recruiting
Kodiak Research Center
Ladson, South Carolina · Recruiting
Kodiak Research Center
Mt. Pleasant, South Carolina · Recruiting
Kodiak Research Center
West Columbia, South Carolina · Recruiting
Kodiak Research Center
Sioux Falls, South Dakota · Recruiting
Kodiak Research Center
Amarillo, Texas · Recruiting
Kodiak Research Center
Arlington, Texas · Recruiting
Kodiak Research Center
Austin, Texas · Recruiting
Kodiak Research Center
Bellaire, Texas · Recruiting
Kodiak Research Center
Fort Worth, Texas · Recruiting
Kodiak Research Center
Katy, Texas · Recruiting
Kodiak Research Center
Plano, Texas · Recruiting
Kodiak Research Center
Round Rock, Texas · Recruiting
Kodiak Research Center
San Antonio, Texas · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.